Key result
Cardiorenal syndrome management remains challenging due to heterogeneous pathophysiology and lack of treatment consensus.
Why the study?
Determining cardiorenal syndrome subgroups is difficult in most clinical settings due to complex pathophysiology and poorly understood pathways, creating challenges in acute and chronic management.
This review provides an overview of the definition, classification, pathophysiology, and treatment of cardiorenal syndrome.
Answers are grounded in this paper and cite their sources.
Management of cardiorenal syndrome remains challenging without consensus; leaves open the need for targeted trials to guide therapy.
Cardiorenal syndrome is a complex clinical condition affecting both the kidney and the heart. It is divided into 5 different subgroups according to various clinical features. However, in most clinical settings this is difficult to determine because the pathophysiology is complex and the pathways are poorly understood. Given this complex clinical situation, many challenges arise in the management of both acute and chronic cardiorenal syndrome. In this review, the definition, classification, pathophysiology and treatment of cardiorenal syndrome are examined.
No takes yet. Share an insight, caveat, or question.
Mehmet Şahinbaş (2024) conducted a review in Cardiorenal syndrome. Cardiorenal syndrome is a complex condition affecting both the kidney and the heart, with management remaining challenging due to its heterogeneous pathophysiology and lack of consensus on treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: